Certified by Founder Lodge
Labviva
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $20,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Revolutionizing life sciences procurement.
AI-powered digital marketplace for complete transparency into your supply chain
Labviva integrates with your existing purchasing software to
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 28 ,2023 | Series A | $20,000,000 | |
| January, 14 ,2025 | Series B | $25,000,000.00 | |
| January, 14 ,2025 | Series B | $25,000,000.00 |
B Capital
Glasswing Ventures
Biospring Partners
Senator Investment Group LP
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
